Neiman Nix v. ESPN, Inc. ( 2019 )


Menu:
  •                                                              [DO NOT PUBLISH]
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE ELEVENTH CIRCUIT
    ________________________
    No. 18-14107
    Non-Argument Calendar
    ________________________
    D.C. Docket No. 1:18-cv-22208-UU
    NEIMAN NIX,
    DNA SPORTS PERFORMANCE LAB, INC.,
    Plaintiffs - Appellants,
    versus
    ESPN, INC.,
    THE ASSOCIATED PRESS, INC.,
    USA TODAY,
    Defendants - Appellees.
    ________________________
    Appeal from the United States District Court
    for the Southern District of Florida
    ________________________
    (May 15, 2019)
    Before WILSON, MARTIN, and NEWSOM, Circuit Judges.
    PER CURIAM:
    This appeal arises out of a defamation action brought by Neiman Nix and
    DNA (collectively, Appellants) against three media companies (collectively,
    Appellees) who published or republished a news article reporting on a lawsuit that
    Nix filed against the MLB. The Appellees filed a motion to dismiss and asserted
    several defenses. The district court applied New York law and dismissed the case
    with prejudice. Appellants now appeal, arguing that the court erred in (1) deciding
    to apply New York law, (2) determining that the fair report privilege and wire
    service defenses warranted dismissal, and (3) concluding that the statements at
    issue in the articles were true and did not have a defamatory implication. We
    disagree with Appellants and affirm.
    I.
    In 2012, Nix opened a sports training center, DNA Sports Performance Lab,
    Inc., in Florida. In addition to providing training services, DNA sells health
    supplements, including a supplement derived from elk antler tissue that contains a
    naturally occurring compound called IGF-1. DNA claims that the supplement has
    many health benefits that improve athletic performance.
    In 2013, the MLB launched an investigation into the illegal sale of
    performance enhancing drugs to MLB players. The investigation targeted clinics
    in Florida, including DNA. Nix filed a tortious interference suit against the MLB
    in the Southern District of New York for harm to his reputation resulting from the
    investigation. On the same day, the Associated Press (AP) published a news article
    about Nix’s lawsuit against the MLB. ESPN and USA Today then republished the
    2
    reported information in their own articles. Each article contained the following
    statement about Nix’s suit against the MLB: “The suit admits Nix and his company
    used bioidentical insulin like growth factor (IGF-1), which is derived from elk
    antlers and is on baseball’s list of banned substances.”1
    Twenty months later, Appellants sued all three media companies in Florida
    state court, seeking injunctive relief via removal or retraction of the articles and
    damages for defamation and intentional infliction of emotional distress. Appellees
    successfully removed the case to federal district court. Appellants alleged that the
    statement about Nix’s ongoing suit against the MLB was incorrect and falsely
    suggested that he sold banned substances to MLB players. Furthermore,
    Appellants contended that the statement did not distinguish between natural and
    synthetic forms of IGF-1, and thus wrongly implied that Appellants sold illegal
    drugs, or legal drugs in an illegal manner.
    Appellees moved to dismiss the complaint, and the district court granted
    dismissal with prejudice. The district court applied New York law, determining
    that (1) Appellants’ defamation claim was barred by New York’s one year statute
    of limitations, (2) the Appellees’ statements fell within New York’s absolute fair
    report privilege, (3) ESPN and USA could successfully apply a wire service
    1
    The MLB Prohibited Substances List includes “Insulin-like Growth Factor (IGF-1), including
    all isomers of IGF-1 sometimes referred to as Mechano Growth Factors.” The description does
    not include the source of the substance or limit the prohibition to synthetic IGF-1.
    3
    defense, and (4) Appellees’ statements were true and thus not defamatory.
    Appellants now appeal, asserting that the district court wrongly applied New York
    law in dismissing this case. Appellants further assert that the district court erred in
    determining that the fair report privilege and wire service defenses warranted
    dismissal of its defamation claims. Finally, Appellants argue that the district court
    erred in determining that the statements at issue were true and could not plausibly
    be interpreted to have a defamatory implication.
    II.
    We review the grant of a motion to dismiss de novo, “accepting the
    allegations in the complaint as true and construing them in the light most favorable
    to the plaintiff.” Miljkovic v. Shafritz & Dinkin, P.A., 
    791 F.3d 1291
    , 1296–97
    (11th Cir. 2015) (quoting Hill v. White, 
    321 F.3d 1334
    , 1335 (11th Cir. 2003) (per
    curiam)). We review a choice of law determination de novo and review the factual
    findings underpinning that determination for clear error. Grupo Televisa, S.A. v.
    Telemundo Commc’ns Grp., Inc., 
    485 F.3d 1233
    , 1239 (11th Cir. 2007).
    “A federal court sitting in diversity will apply the conflict-of-laws rules of
    the forum state” based on the particular legal issues in the case. 
    Id. at 1240
    . When
    faced with a conflict of laws in a torts case, Florida courts apply the “most
    significant relationship” test outlined in the Restatement (Second) of Conflict of
    Laws § 145. Id. The test lists four factors that courts must consider with respect to
    4
    each claim: (1) the place where the injury occurred; (2) the place where the
    conduct causing the injury occurred; (3) the domicile, residence, nationality, place
    of incorporation, and place of business of the parties; and (4) the place where the
    relationship, if any, between the parties is centered. Id. “These factors are
    considered according to their relative importance with respect to the particular
    issue.” Michel v. NYP Holdings, Inc., 
    816 F.3d 686
    , 694 (11th Cir. 2016) (internal
    quotation marks omitted). If the court cannot draw a conclusion based on these
    four factors, it may then consider the seven factors outlined in the Restatement
    (Second) of Conflict of Laws § 6. 2 Grupo Televisa, 
    485 F.3d at 1240
    . The seven
    factors are not exclusive and the court may give different weight to particular
    factors, or consider other factors in deciding a question of choice of law.
    Restatement (Second) of Conflict of Laws § 6 (1971).
    The Restatement (Second) of Conflict of Laws § 150 also states that when
    defamatory information is published in more than one state, the “state of most
    significant relationship” will usually be the state where the plaintiff was domiciled
    or had its principal place of business at the time. This is premised on the notion
    that the plaintiff will usually suffer greatest injury—by reason of loss of
    reputation—in the state of domicile or principal place of business. There are
    2
    These seven factors include: (1) the needs of interstate and international systems; (2) relevant
    policies of the forum; (3) relevant policies of other interested states and the relative interests of
    those states in the determinations of the particular issue; (4) protection of justified expectations;
    (5) basic policies underlying the particular field of law; (6) certainty, predictability and
    uniformity of result, and (7) ease in the determination and application of the law to be applied.
    5
    situations, however, in which the state of most significant relationship is not where
    the plaintiff was domiciled or had its principal place of business, but rather the
    state where the plaintiff suffered greater injury. For example, a plaintiff may suffer
    greater injury in another state if the defamatory matter “related to an activity of the
    plaintiff that is principally located in [that] state,” or “the plaintiff suffered greater
    special damages in [that] state than in the state of his domicil.” Id.; see also
    Michel, 816 F.3d at 694 (applying New York law in a defamation suit brought by a
    Florida resident in part because “the article was published in New York, regarding
    an event that took place in New York, and that allegedly caused harm to
    [plaintiff’s] business interests in New York,” and “[all defendants] are domiciled in
    New York.”).
    III.
    In the present case, there is a conflict of laws with respect to affirmative
    defenses to defamation asserted by Appellee AP. First, Appellees assert that
    Appellants failed to bring their defamation claim within the one year statute of
    limitations under New York law. N.Y. C.P.L.R. 215(3) (McKinney 2006). This
    claim would have been timely under Florida law, which provides two years to
    bring a defamation claim. 
    Fla. Stat. § 95.11
    (4)(g) (West 2018). Second, Appellees
    assert that the fair report privilege applies. Florida law recognizes only a qualified
    fair report privilege. See Woodard v. Sunbeam Television Corp., 
    616 So. 2d 501
    ,
    6
    502 (Fla. 3d DCA 1993). In contrast, New York law recognizes an absolute fair
    report privilege which may serve as a basis to dismiss a complaint at the pleading
    stage. See Cholowsky v. Civiletti, 
    69 A.D.3d 110
    , 114 (N.Y. App. 2009)
    (recognizing absolute fair report privilege for judicial proceedings); Adelson v.
    Harris, 
    973 F. Supp. 2d 467
     (S.D.N.Y. 2013), aff’d 
    876 F.3d 413
     (2d Cir. 2017)
    (same). 3
    The district court applied Florida’s four-factor “most significant relationship
    test” to conclude that New York law applied. The court determined that the first
    factor of the test—the place where the injury occurred—weighed “somewhat” in
    favor of New York. The allegedly defamatory information was published online
    and accessible anywhere but caused the greatest injury in New York. Appellants
    generally alleged injuries in both New York and Florida, but Appellants only
    alleged specific injuries in New York. In particular, the allegedly defamatory
    information from the articles was used against Nix in a lawsuit in New York and
    obstructed Appellants’ attempt to expand their business to Manhattan. We agree
    with the district court’s factual findings and application of the first factor.
    The court then determined that the second factor—the place where the
    conduct occurred—also weighed “somewhat” in favor of New York. Once again,
    although the articles were published online and accessible anywhere, the decision
    3
    Because we agree with the district court’s application of New York law, we will not evaluate
    whether Florida’s qualified fair report privilege would have served as a successful defense here.
    7
    to publish the allegedly defamatory information was first made by Appellee AP,
    which is headquartered in New York. We agree that this weighs only somewhat in
    favor of New York.
    The court then determined that the third factor—the location of the parties—
    was “neutral” because all parties were from different locations. All Appellees
    were incorporated in different states, and the district court made a factual
    determination that Appellants’ locations were uncertain and thus could not provide
    weight for any particular state.
    Appellants argue that the district court did not correctly determine the
    location of the parties and did not give enough weight to the fact that both
    Appellants were located in Florida. Appellants assert that, had the court properly
    recognized that both Appellants were located in Florida, the court would have
    found that Florida was the state of most significant relationship, because it was the
    state of both Appellants’ respective domiciles and DNA’s principal place of
    business. The court, however, found that the Appellants’ respective locations were
    uncertain because Appellants did not clearly allege in their complaint that Florida
    was Nix’s domicile or DNA’s principal place of business. The complaint never
    stated that Nix was a citizen of, or residing in, Florida; and although the complaint
    8
    did state that DNA was a “Florida corporation,” Appellants never alleged in their
    complaint that Florida was DNA’s principal place of business. 4
    Appellants later attached an affidavit in response to Appellees’ motion to
    dismiss, alleging that Nix had been domiciled in Florida at all relevant times. The
    district court noted that Appellants could not amend their complaint through this
    response. The court further added that Nix had alleged permanent residence in
    Texas when he filed suit against the MLB in the Southern District of New York,
    suggesting that he might be lying about his domicile in at least one of his suits.
    The district court did not clearly err in its factual findings with respect to the
    location of the parties. The court could have found that DNA, a “Florida
    corporation,” was located solely in Florida. However, the Appellants did not write
    in their complaint that DNA’s principal place of business was in Florida. The
    complaint also failed to state that Nix was domiciled in Florida. The district court
    thus concluded that Appellants’ locations were uncertain, especially in light of
    additional information suggesting that Nix may have been in Texas when the
    allegedly defamatory information was published. If Nix were in Texas, then all
    parties would be from different locations at the time of suit. This was not a clearly
    4
    The complaint states that Nix started his first business in Seattle, Washington and this business
    expanded to Clearwater, Florida. Nix then “launched a new business in the form a [sic] state-of-
    the-art sports science center in Miami Beach, Florida in April of 2012.” This new business was
    DNA. The complaint never clearly states that Florida was DNA’s principal place of business,
    nor does it provide any further information to support such a claim.
    9
    erroneous factual finding, and the court properly applied the relevant legal factor to
    this finding, ultimately concluding that the factor was of “neutral” weight.
    Finally, the district court determined that the fourth factor—the relationship
    of the parties—was of neutral weight because the parties did not allege any
    relationship outside of the defamation suit. The district court also appeared to give
    some weight to one of the seven factors listed in the Restatement (Second) of
    Conflict of Laws § 6, noting that New York had an interest in determining the
    application of affirmative defenses to litigation. Many of the factors listed in § 6
    do not weigh heavily in favor of either state; thus, they are not particularly useful
    in determining which state law to apply. Considering the totality of these factors,
    it appears that the test weighs somewhat in favor of New York law.
    After applying the “most significant relationship” test, the district court
    correctly determined that New York law applied to the two affirmative defenses.
    The court first applied New York’s one year statute of limitations to Appellants’
    defamation claim, starting on the date of “the first publication of the defamatory
    statement,” and concluded that Appellants had brought the claim eight months too
    late. See Firth v. State, 
    775 N.E.2d 463
    , 464–65 (N.Y. 2000). We therefore affirm
    the district court’s dismissal of Appellants’ defamation claim on this ground.
    The district court also applied New York law to Appellees’ fair report
    privilege defense. Under New York law, “[a] civil action cannot be maintained
    10
    against any person, firm or corporation, for the publication of a fair and true report
    of any judicial proceeding, legislative proceeding or other official
    proceeding . . . .” 
    N.Y. Civ. Rights Law § 74
     (McKinney 2019). A report is “fair
    and true” within the meaning of this statute if “the substance of the article [is]
    substantially accurate.” D’Annunzio v. Ayken, Inc., 
    876 F. Supp. 2d 211
    , 217
    (E.D.N.Y. 2012). “A report is ‘substantially accurate’ if, despite minor
    inaccuracies, it does not produce a different effect on a reader than would a report
    containing the precise truth.” Zerman v. Sullivan & Cromwell, 
    677 F. Supp. 1316
    ,
    1322 (S.D.N.Y. 1988).
    When the parties submit allegedly defamatory information to a court, that
    court “may determine as a matter of law whether allegedly defamatory publications
    are ‘fair and true’ reports of official proceedings.” Aguirre v. Best Care Agency,
    Inc., 
    961 F. Supp. 2d 427
    , 457 (E.D.N.Y. 2013). Reports “must be accorded some
    degree of liberality,” and if it is not misleading and is “composed and phrased in
    good faith under the exigencies of a publication deadline,” the report should not be
    “parsed and dissected on the basis of precise denotative meanings which may
    literally, although not contextually, be ascribed to the words used.” Holy Spirit
    Ass’n for Unification of World Christianity v. New York Times Co., 
    399 N.E.2d 1185
    , 1187 (N.Y. 1979). “It is sufficient that the plaintiff’s complaint or
    documents referred to therein form the basis for each of the contested statements.”
    11
    D’Annunzio, 876 F. Supp. 2d at 217–18. Statements in a report will not be
    protected, however, if they “imply misconduct beyond that alleged in the judicial
    proceeding on which the report is based.” Id.
    In the present case, Appellants submitted the allegedly defamatory statement
    to the district court in their complaint. The allegedly defamatory statement
    describes a suit that Nix brought against the MLB in the Southern District of New
    York. The statement reads: “The suit admits Nix and his company used
    bioidentical insulin like growth factor (IGF-1), which is derived from elk antlers
    and is on baseball’s list of banned substances.” In his suit against the MLB, Nix
    alleged in his complaint that “[o]ne of the main ingredients used by Nix and DNA
    Sports Lab come [sic] from Bio-identical Insulin like Growth Factor (“IGF-1”),
    which is derived from elk antlers.”
    Nix also included in that complaint language from MLB’s publicly available
    list of banned substances. Specifically, the relevant language included: “Any and
    all anabolic androgenic steroids covered by Schedule III of the Code of Federal
    Regulations’ Schedule of Controlled Substances (“Schedule III”), as amended
    from time to time, and the categories of hormones and agents with antiestrogenic
    activity that are set forth in Nos. 67–74, below, shall be considered Performance
    12
    Enhancing Substances covered by the Program.” 5 IGF-1 appears at Number 68 on
    that list, and is described as “Insulin-like Growth Factor (IGF-1), including all
    isomers of IGF-1 sometimes referred to as Mechano Growth Factors.” Although
    Appellants seek to distinguish between natural and synthetic IGF-1, the MLB’s list
    does not make such a distinction.
    Nix’s complaint in his suit against the MLB stated that his products
    contained IGF-1 derived from elk antlers. The MLB’s list of banned substances
    includes all isomers of IGF-1. The statement at issue simply combined these two
    facts. The district court correctly concluded, based on this information, that
    Appellees’ statements were substantially correct, and fell within the protection of
    the fair report privilege.
    IV.
    Appellants also argue that the wire service defense should not protect
    Appellees ESPN or USA Today, the republishers of AP’s original statement. Both
    Florida and New York law provide that, when one news agency “republishes the
    content of a news story that was originally published by another reputable news
    agency or source,” the republisher will not be liable if they relied “on the research
    5
    Appellants contend that natural IGF-1 is not a Schedule III Controlled Substance, and therefore
    does not fall within the MLB’s list of banned substances. Appellants ignore, however, the
    italicized language immediately following the sentence about Schedule III Controlled
    Substances. The italicized language makes clear that the list of banned substances includes
    hormones and agents with antiestrogenic activity described in numbers 67–74. All isomers of
    IGF-1, described in number 68 on the banned substances list, fall into this category of banned
    substances.
    13
    of the original publisher, ‘absent a showing that the republisher had, or should have
    had, substantial reasons to question the accuracy of the articles or the bona fides of
    [the] reporter.’” Rakofsky v. Washington Post, 
    2013 WL 1975654
    , *12 (N.Y. Sup.
    Ct. April 29, 2013); Layne v. Tribune Co., 
    146 So. 234
    , 238–39 (Fla. 1933); see
    also Miami Herald Pub. Co. v. Ane, 
    458 So. 2d 239
    , 242 (Fla. 1984) (summarizing
    Layne’s conclusion that a newspaper’s “privilege to publish an apparently
    authentic news dispatch received from and attributed to a generally recognized
    reputable news service agency (such as the Associated Press or Universal Press) in
    the absence of a showing that the publisher acted in a “negligent, reckless, or
    careless manner”).
    Here, AP—a reputable news source—published an article with a statement
    that was a substantially accurate summary of judicial proceedings. Appellants did
    not assert facts to show, and there is nothing else to suggest, that ESPN or USA
    Today were negligent, reckless, or careless in relying on AP’s content. The district
    court thus correctly concluded that the republishers of this statement—ESPN and
    USA Today—prevail on their wire service defenses.
    V.
    Finally, Appellants assert that the district court erred as a matter of law in
    determining that Appellees’ statements were not defamatory. “True statements,
    statements that are not readily capable of being proven false, and statements of
    14
    pure opinion are protected from defamation actions by the First Amendment.”
    Turner v. Wells, 
    879 F.3d 1254
    , 1262 (11th Cir. 2018). “Whether the statement is
    one of fact or opinion and whether a statement of fact is susceptible to defamatory
    interpretation are questions of law for the court.” 
    Id.
     at 1262–63. In Turner v.
    Wells, we rejected a plaintiff’s claim of defamation by implication, emphasizing
    that courts afford news media editorial discretion. Id. at 1269.
    If a defendant “juxtaposes a series of facts so as to imply a defamatory
    connection between them, or creates a defamatory implication by omitting facts, he
    may be held responsible for the defamatory implication, unless it qualifies as an
    opinion, even though the particular facts are correct.” Id. A statement “is not
    considered false unless it ‘would have a different effect on the mind of the reader
    from that which the pleaded truth would have produced.’” Masson v. New Yorker
    Magazine, Inc., 
    501 U.S. 496
    , 517, 
    111 S. Ct. 2419
    , 2433 (1991).
    Appellants allege that the Appellees published or republished statements that
    did not specify whether Appellants sold synthetic or natural IGF-1, and this
    omission implied that Appellants sold illegal drugs. But the alleged omission did
    not make the statements untrue. The statements accurately reported available
    information without creating a defamatory implication. Appellants admit that they
    sell IGF-1, which is derived from elk antlers. The MLB Prohibited Substances List
    includes “Insulin-like Growth Factor (IGF-1), including all isomers of IGF-1
    15
    sometimes referred to as Mechano Growth Factors.” The List does not describe
    the source of the substance or distinguish between synthetic and natural IGF-1.
    Therefore, the omission of any distinction between synthetic and natural IGF-1
    does not render the statements untrue or defamatory.
    Appellants also argue that the articles included references to an ongoing
    MLB drug use scandal and to a lawyer who defended an MLB player who had
    tested positive for illegal substances several times, which created a defamatory
    implication in combination with the other facts provided. The drug scandal was
    discussed extensively in Appellants’ complaint upon which the articles were
    reporting, and the complaint was filed by the lawyer referred to in the articles. The
    articles did not imply a defamatory connection between these facts and the fact that
    Appellants sold IGF-1.
    VI.
    We conclude that the district court did not err in applying New York law to
    the statute of limitations and fair report privilege defenses. Both defenses served
    to defeat Appellants’ defamation claims here. Furthermore, the district court
    correctly determined that ESPN and USA Today’s wire service defenses warranted
    dismissal, and finally that the statements at issue were true and lacked a
    defamatory implication. Accordingly, we affirm.
    AFFIRMED.
    16